Amgen
Pioneer biotech company (+17% growth in 2024). Leaders in biologics for cancer, bone health, and inflammatory conditions.
Services Offered
Our Take
Amgen is a biotech pioneer with 17% revenue growth in 2024. They're particularly important for bone health (Prolia, Evenity for osteoporosis) and have a growing biosimilar portfolio offering cheaper alternatives to expensive drugs. Their Safety Net Foundation and FIRST STEP copay program can significantly reduce costs.
Pros
- ✓+17% revenue growth (2024)
- ✓Safety Net Foundation for free meds
- ✓FIRST STEP copay assistance
- ✓Strong biosimilar portfolio (cheaper alternatives)
- ✓Pioneer biotech with decades of experience
Cons
- ✗Biologics expensive without help
- ✗Specialty pharmacy often required
- ✗Some drugs have complex dosing
- ✗Insurance navigation needed
Pricing Details
Amgen Safety Net Foundation provides free medications to qualifying patients. AMGEN FIRST STEP program offers copay assistance.
Best For
- • Bone health/osteoporosis
- • Cancer treatment
- • Inflammatory conditions
- • Biosimilar alternatives
Coverage
- 📍 Global
Accreditations
- ✓FDA approved
Trust Indicators
Years in Business
44+
Last verified: December 21, 2024
⚠️ Important
Always verify pricing and details directly with the provider. Prices shown are estimates based on our research as of December 2024 and may have changed.
This information is for educational purposes only and does not constitute medical advice. Consult with qualified healthcare professionals before making medical decisions.
We may earn a commission if you use our links, but this does not affect our editorial opinions or the information presented.
Opens in new window • direct link